tirzepatide seattle weight loss patients fret over FDA limits on off-brand drugs TIRZEPATIDE – Research Peptide |

The FDA issued a warning letter dated March 5, relying on five incidences in which people prescribed the medications had an adverse event associated with the medication such as a stroke, suicidal ideations or even passed away by suicide all of which Novo Nordisk allegedly refused to properly report to the FDA

One MyPsoriasisTeam member shared, The doctor put me on Wegovy for weight loss, and fatigue is a side effect

Who Should Evaluate GLP-1 Use in Hashimoto's and What to Discuss Patients with Hashimoto's who are candidates for GLP-1 therapy must have separate clinical indication (obesity, type 2 diabetes, cardiovascular risk) and stable thyroid disease controlled on levothyroxine

It says some provinces cover semaglutide or tirzepatide for diabetes under specific circumstances, while weight-management indications often require private payment or a specialized plan